However, even without the underlying molecular mechanisms, the observation that T2R signaling to eNOS is disrupted in CF cells and is restored with CFTR corrector/potentiator therapies may be useful for understanding contributing factors to CF lung infections. The gene discussed is NOS3; the disease is cystic fibrosis.